10 Best Cheap Stocks to Buy Under $10

4. Viatris Inc. (NASDAQ:VTRS)

Share Price as of April 22: $7.57

Forward P/E Ratio as of April 22: 3.52

Number of Hedge Fund Holders: 48

Viatris Inc. (NASDAQ:VTRS) is a healthcare company that operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, and biosimilars. It also provides drugs in various therapeutic areas and covers various noncommunicable and infectious diseases.

In 2024, Viatris’ base business, which includes core generics, complex generics, and novel products, made $582 million in new product revenues. The base business pipeline annually sees more than 100 submissions. The company has delivered over $450 million in new product revenues for each of the past 5 years. For 2025, Viatris set a target range of $450 million to $550 million in new product revenues.

Viatris Inc. (NASDAQ:VTRS) is also progressing its novel and life cycle management programs within the base business. The company anticipates several Phase 3 readouts in 2025, including Effexor for Generalized Anxiety Disorder in Japan, Xulane Low Dose for low-dose estrogen combination birth control, and Meloxicam for acute pain.